Trilok Parekh
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Reproductive Medicine top 1%
- Hematology top 2%
- Co-authors
- Leslie I. GoldRoland E. KnoblauchYoun Choi ParkAndrés PovedaAlexander I. SpiraMargaret von MehrenGeorge D. DemetriBradley J. Monk
- Topics
- Ovarian cancer diagnosis and treatment (20 papers)Sarcoma Diagnosis and Treatment (18 papers)Multiple Myeloma Research and Treatments (13 papers)
- Partner nations
- United StatesSpainBelgium
In The Last Decade
Trilok Parekh
61 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 908
- Molecular Biology 875
- Reproductive Medicine 489
- Hematology 478
Countries citing papers authored by Trilok Parekh
This map shows the geographic impact of Trilok Parekh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trilok Parekh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trilok Parekh more than expected).
Fields of papers citing papers by Trilok Parekh
This network shows the impact of papers produced by Trilok Parekh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trilok Parekh. The network helps show where Trilok Parekh may publish in the future.
Co-authorship network of co-authors of Trilok Parekh
This figure shows the co-authorship network connecting the top 25 collaborators of Trilok Parekh. A scholar is included among the top collaborators of Trilok Parekh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trilok Parekh. Trilok Parekh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 187 | |
| 4 | 2 | |
| 5 | 46 | |
| 6 | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trialbreakdown → | 576 |
| 7 | 53 | |
| 8 | 5 | |
| 9 | 5 | |
| 10 | 9 | |
| 11 | 44 | |
| 12 | 137 | |
| 13 | 7 | |
| 14 | 117 | |
| 15 | 47 | |
| 16 | 54 | |
| 17 | 28 | |
| 18 | Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. | 58 |
| 19 | 23 | |
| 20 | 21 |
About Trilok Parekh
Trilok Parekh is a scholar working on Reproductive Medicine, Hematology and Cancer Research, having authored 64 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (20 papers), Sarcoma Diagnosis and Treatment (18 papers) and Multiple Myeloma Research and Treatments (13 papers). The work is most often cited by research in Reproductive Medicine (489 citations), Oncology (1.3k citations) and Hematology (478 citations). Trilok Parekh has collaborated with scholars based in United States, Spain and Belgium. Frequent co-authors include Leslie I. Gold, Roland E. Knoblauch, Youn Choi Park, Andrés Poveda, Alexander I. Spira, Margaret von Mehren, George D. Demetri, Bradley J. Monk, Robert G. Maki and Shreyaskumar Patel. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.